🔗 Permalink

Inventor profile of:

Dennis A. Carson

City:

La Jolla, California

Country:

United States

Published Applications:

Last publication date:

2025-09-11

Top Assignees for applications by Dennis A. Carson

The entities that hold a legal rights for patent applications filed by inventor Carson Dennis A.:

The Regents of the University of California 16 Oakland, CA United States
REGENTS OF THE UNIVERSITY OF CALIFORNIA 2 Oakland, CA United States
The Regents of the University of California Office of Technology Transfer 1 Oakland, CA United States
THE REGENTS OF UNIVERSITY OF CALIFORNIA 1 Oakland, CA United States
The Regents of the The University of California 1 Oakland, CA United States
CEPHALON, INC. 1 FRAZER, PA United States
Regents of the University of California, San Diego UCSD Technology Transfer Office 1 La Jolla, CA United States
Regents of the University of California, San Diego 1 La Jolla, CA United States

Recent patent applications by Carson Dennis A.

Dennis A. Carson from La Jolla, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-11

US20250281465A1

Human necessities

MOLECULES THAT ENHANCE EXTRACELLULAR VESICLE RELEASE

#2 | 2023-11-16

US20230365570A1

Chemistry; metallurgy

COMPOUNDS WITH GLUCOCORTICOID SPARING EFFECTS AND USES THEREOF

#3 | 2022-09-29

US20220305121A1

Human necessities

N-ARYL SULFONAMIDE DERIVATIVES AS VACCINE ADJUVANT

#4 | 2022-05-19

US20220152188A1

Human necessities

TLR4-TLR7 LIGAND FORMULATIONS AS VACCINE ADJUVANTS

#5 | 2020-03-19

US20200087625A1

Chemistry; metallurgy

METHODS FOR ISOLATING, EXPANDING AND ADMINISTERING CANCER SPECIFIC CD8+ T CELLS

#6 | 2018-04-26

US20180110784A1

Human necessities

SYNTHETIC TLR4 AND TLR7 LIGANDS TO PREVENT, INHIBIT OR TREAT LIVER DISEASE

#7 | 2017-11-30

US20170342504A1

Chemistry; metallurgy

Early ovarian cancer detection diagnostic test based on mRNA isoforms

#8 | 2016-07-14

US20160199499A1

Human necessities

USES OF PHOSPHOLIPID CONJUGATES OF SYNTHETIC TLR7 AGONISTS

#9 | 2015-12-24

US20150366962A1

Human necessities

SYNTHETIC TLR4 AND TLR7 LIGANDS AS VACCINE ADJUVANTS

#10 | 2015-07-16

US20150197527A1

Chemistry; metallurgy

Compositions and methods for modulating TLR4

#11 | 2015-05-14

US20150132342A1

Chemistry; metallurgy

NOVEL IMMUNE ACTIVATORS: SUBSTITUTE 4-AMINOQUINAZOLINES

#12 | 2014-10-09

US20140302120A1

Human necessities

Conjugates of synthetic TLR agonists and uses therefor

#13 | 2013-08-08

US20130202629A1

Human necessities

USES OF PHOSPHOLIPID CONJUGATES OF SYNTHETIC TLR7 AGONISTS

#14 | 2013-07-25

US20130190494A1

Human necessities

PURINE ANALOGS

#15 | 2013-06-27

US20130165455A1

Chemistry; metallurgy

TLR agonists

#16 | 2013-06-20

US20130156807A1

Chemistry; metallurgy

Conjugates of synthetic TLR agonists and uses therefor

#17 | 2012-06-14

US20120148660A1

Human necessities

Conjugates of synthetic TLR agonists and uses therefor

#18 | 2011-12-15

US20110306671A1

Human necessities

AMIDE DERIVATIVES OF ETHACRYNIC ACID

#19 | 2011-04-28

US20110098294A1

Chemistry; metallurgy

Purine analogs

#20 | 2010-08-19

US20100210598A1

Chemistry; metallurgy

Toll-like receptor modulators and treatment of diseases

#21 | 2010-04-08

US20100086918A1

Chemistry; metallurgy

Methods for High Sensitivity Detection of Genetic Polymorphisms

#22 | 2009-12-31

US20090324551A1

Chemistry; metallurgy

TLR AGONISTS

#23 | 2009-08-13

US20090202626A1

Human necessities

TREATMENT OF BLADDER DISEASES WITH A TLR7 ACTIVATOR

#24 | 2008-11-13

US20080280903A1

Chemistry; metallurgy

Apoptosis inhibitors

#25 | 2007-12-27

US20070299042A1

Human necessities

USE OF ETODOLAC TO TREAT HYPERPLASIA

#26 | 2007-05-01

US10667208

Use of etodolac to treat hyperplasia

#27 | 2006-12-28

US20060293253A1

Human necessities

Indole compounds useful for the treatment of cancer

#28 | 2006-06-08

US20060122178A1

Chemistry; metallurgy

Compounds having activity as inhibitors of apoptosis

#29 | 2005-10-27

US20050239752A1

Chemistry; metallurgy

Indole compounds useful for the treatment of cancer

#30 | 2005-07-14

US20050154010A1

Human necessities

Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogs

#31 | 2005-06-16

US20050130199A1

Chemistry; metallurgy

Mutations in WNT-frizzled signaling pathways associated with osteoarthritis

#32 | 2005-01-06

US20050004144A1

Human necessities

Combined use of IMPDH inhibitors with toll-like receptor agonists

InventorID:

298773 ⎘